Both in Lab Analytical Instruments
10x Genomics vs Bruker
Over the past year TXG returned +349.9% and BRKR returned +43.9%; their daily moves had a correlation of 0.56.
TXG +349.9% BRKR +43.9%Growth of $1, one year, split-adjusted
| Metric | TXG | BRKR |
|---|---|---|
| Price | $61.63 | $55.69 |
| Market cap | $8.03B | $8.48B |
| Today | −12.10% | −2.42% |
| 1 month | −34.1% | −11.9% |
| 6 months | +184.7% | +53.0% |
| Year to date | +277.9% | +18.2% |
| 1 year | +395.4% | +53.0% |
| Revenue growth (YoY) | −12.6% | +5.2% |
| Gross margin | 74.5% | 49.6% |
| Net margin | −11.9% | −7.5% |
| P/E (TTM) | — | — |
| Price / sales | 13.0× | 2.4× |
| Net cash | $552.0M | -$1.64B |
| Dividend yield | — | 0.36% |
| Volatility (60d) | 88.2% | 51.9% |
| Short % of float | 10.9% | 11.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).